Neurology/psychiatric https://www.bioworld.com/rss en-us Abbvie nabs two Nav1.8 pain projects from Haisco in $745M deal http://www.bioworld.com/articles/730297 Tue, 14 Apr 2026 12:00:00 -0400 https://www.bioworld.com/articles/730297-abbvie-nabs-two-nav18-pain-projects-from-haisco-in-745m-deal Open capsule delivering pain relief to body Researchers unveil REDD1 as target for major depression http://www.bioworld.com/articles/730350 Tue, 14 Apr 2026 09:00:00 -0400 https://www.bioworld.com/articles/730350-researchers-unveil-redd1-as-target-for-major-depression Man sitting on bed holding head Investment to advance Quiver’s ASO for Dup15q syndrome http://www.bioworld.com/articles/730349 Tue, 14 Apr 2026 09:00:00 -0400 https://www.bioworld.com/articles/730349-investment-to-advance-quivers-aso-for-dup15q-syndrome Illustration of human brain and dna Novel caspase-2 inhibitor shows in vivo neuroprotective effects http://www.bioworld.com/articles/730346 Tue, 14 Apr 2026 09:00:00 -0400 https://www.bioworld.com/articles/730346-novel-caspase-2-inhibitor-shows-in-vivo-neuroprotective-effects Abbvie licenses ex-China rights to Haisco pain compounds http://www.bioworld.com/articles/730326 Mon, 13 Apr 2026 09:00:00 -0400 https://www.bioworld.com/articles/730326-abbvie-licenses-ex-china-rights-to-haisco-pain-compounds 3D illustration of a nerve cell Realta secures another $40M for its hypoxic ischemic encephalopathy treatment http://www.bioworld.com/articles/730228 Fri, 10 Apr 2026 12:00:00 -0400 https://www.bioworld.com/articles/730228-realta-secures-another-40m-for-its-hypoxic-ischemic-encephalopathy-treatment Photo of hands holding a baby PMP22-RNAi gives long-lasting protection in Charcot-Marie-Tooth Charcot-Marie-Tooth type 1A.]]> http://www.bioworld.com/articles/730260 Fri, 10 Apr 2026 09:00:00 -0400 https://www.bioworld.com/articles/730260-pmp22-rnai-gives-long-lasting-protection-in-charcot-marie-tooth MSD discloses new HCN1/2 blockers http://www.bioworld.com/articles/730252 Thu, 09 Apr 2026 09:00:00 -0400 https://www.bioworld.com/articles/730252-msd-discloses-new-hcn1-2-blockers Sononeu wins $5.2M ARPA-H grant for ultrasound-activated therapeutics http://www.bioworld.com/articles/730256 Wed, 08 Apr 2026 09:00:00 -0400 https://www.bioworld.com/articles/730256-sononeu-wins-52m-arpa-h-grant-for-ultrasound-activated-therapeutics Neuropathy illustrated in legs and feet MMP inhibitors divulged in Accure Therapeutics patent http://www.bioworld.com/articles/730200 Wed, 08 Apr 2026 09:00:00 -0400 https://www.bioworld.com/articles/730200-mmp-inhibitors-divulged-in-accure-therapeutics-patent Sononeu wins $5.2M ARPA-H grant for ultrasound-activated therapeutics http://www.bioworld.com/articles/730136 Tue, 07 Apr 2026 11:00:00 -0400 https://www.bioworld.com/articles/730136-sononeu-wins-52m-arpa-h-grant-for-ultrasound-activated-therapeutics Neuropathy illustrated in legs and feet Orexin OX2 receptor agonists disclosed in Vertex Pharmaceuticals patent http://www.bioworld.com/articles/730176 Tue, 07 Apr 2026 09:00:00 -0400 https://www.bioworld.com/articles/730176-orexin-ox2-receptor-agonists-disclosed-in-vertex-pharmaceuticals-patent Acadia Pharmaceuticals presents GPR88 agonists http://www.bioworld.com/articles/730175 Tue, 07 Apr 2026 09:00:00 -0400 https://www.bioworld.com/articles/730175-acadia-pharmaceuticals-presents-gpr88-agonists Optimization of brain-permeable SGK1 inhibitors for neurodegenerative diseases http://www.bioworld.com/articles/730170 Tue, 07 Apr 2026 09:00:00 -0400 https://www.bioworld.com/articles/730170-optimization-of-brain-permeable-sgk1-inhibitors-for-neurodegenerative-diseases Man piecing together a puzzle Oral ‘roid void in PPD? Lipocine MINI bike may have wheels http://www.bioworld.com/articles/730072 Thu, 02 Apr 2026 12:00:00 -0400 https://www.bioworld.com/articles/730072-oral-roid-void-in-ppd-lipocine-mini-bike-may-have-wheels Tired mother holding newborn Korsana boosts Alzheimer’s work with reverse merger, $380M financing http://www.bioworld.com/articles/730126 Thu, 02 Apr 2026 09:00:00 -0400 https://www.bioworld.com/articles/730126-korsana-boosts-alzheimers-work-with-reverse-merger-380m-financing Connecting puzzle pieces Hengrui discovers new Nav1.8 blockers http://www.bioworld.com/articles/730105 Thu, 02 Apr 2026 09:00:00 -0400 https://www.bioworld.com/articles/730105-hengrui-discovers-new-nav18-blockers Korsana boosts Alzheimer’s work with reverse merger, $380M financing http://www.bioworld.com/articles/729977 Wed, 01 Apr 2026 12:00:00 -0400 https://www.bioworld.com/articles/729977-korsana-boosts-alzheimers-work-with-reverse-merger-380m-financing Connecting puzzle pieces CRISPR-mediated utrophin upregulation preclinically improves DMD http://www.bioworld.com/articles/730056 Wed, 01 Apr 2026 09:00:00 -0400 https://www.bioworld.com/articles/730056-crispr-mediated-utrophin-upregulation-preclinically-improves-dmd Otsuka to acquire PTSD drugmaker Transcend in $1.2B deal http://www.bioworld.com/articles/730090 Tue, 31 Mar 2026 12:00:00 -0400 https://www.bioworld.com/articles/730090-otsuka-to-acquire-ptsd-drugmaker-transcend-in-12b-deal Brain with handshake and cityscape Lilly shifts from obesity to narcolepsy with $7.8B Centessa buy http://www.bioworld.com/articles/729962 Tue, 31 Mar 2026 12:00:00 -0400 https://www.bioworld.com/articles/729962-lilly-shifts-from-obesity-to-narcolepsy-with-78b-centessa-buy Brain with clock hands, day and night background Montclair State, University of Maryland identify PDE11A4 inhibitors http://www.bioworld.com/articles/730051 Tue, 31 Mar 2026 09:00:00 -0400 https://www.bioworld.com/articles/730051-montclair-state-university-of-maryland-identify-pde11a4-inhibitors Funding to advance Marvel’s MB-204 into clinic http://www.bioworld.com/articles/730038 Tue, 31 Mar 2026 09:00:00 -0400 https://www.bioworld.com/articles/730038-funding-to-advance-marvels-mb-204-into-clinic Brain with puzzle piece removed Antitumoral antibodies cross the BBB and alter brain signaling http://www.bioworld.com/articles/730035 Tue, 31 Mar 2026 09:00:00 -0400 https://www.bioworld.com/articles/730035-antitumoral-antibodies-cross-the-bbb-and-alter-brain-signaling Antibodies and synaptic neuron Otsuka to acquire PTSD drugmaker Transcend in $1.2B deal http://www.bioworld.com/articles/729952 Mon, 30 Mar 2026 12:00:00 -0400 https://www.bioworld.com/articles/729952-otsuka-to-acquire-ptsd-drugmaker-transcend-in-12b-deal Brain with handshake and cityscape Targeting PGAM5 slows down ALS progression http://www.bioworld.com/articles/730017 Mon, 30 Mar 2026 09:00:00 -0400 https://www.bioworld.com/articles/730017-targeting-pgam5-slows-down-als-progression Illustration demonstrating muscle contraction in amyotrophic lateral sclerosis. Molecular signatures show subtypes in neurodegenerative diseases http://www.bioworld.com/articles/730013 Mon, 30 Mar 2026 09:00:00 -0400 https://www.bioworld.com/articles/730013-molecular-signatures-show-subtypes-in-neurodegenerative-diseases Illustration of a nerve cell with DNA double helix Small-molecule TREM2 agonist advances to treat Alzheimer’s http://www.bioworld.com/articles/730054 Fri, 27 Mar 2026 12:00:00 -0400 https://www.bioworld.com/articles/730054-small-molecule-trem2-agonist-advances-to-treat-alzheimers Comparison of neurons in a healthy brain and nerve cells in neurodegenerative disease with amyloid plaques Xcath sees Iris robotic platform transforming stroke treatment http://www.bioworld.com/articles/729916 Fri, 27 Mar 2026 12:00:00 -0400 https://www.bioworld.com/articles/729916-xcath-sees-iris-robotic-platform-transforming-stroke-treatment Xcath Team Santiago Control Room Neurosurgeon Dr. Vitor Mendes Pereira controlling the telesurgery system and Dr. Fred Moll, chairman of Xcath, in the Santiago control room. Credit: Xcath Robotics Inc. Atai Therapeutics patents new 5-HT2 receptor agonists http://www.bioworld.com/articles/729940 Thu, 26 Mar 2026 09:00:00 -0400 https://www.bioworld.com/articles/729940-atai-therapeutics-patents-new-5-ht2-receptor-agonists